BioSante (BPAX) continues to soar, up 13.2% today and +21% since being initiated at Outperform...

|By:, SA News Editor

BioSante (BPAX) continues to soar, up 13.2% today and +21% since being initiated at Outperform by Leerink Swann yesterday. The firm is optimistic on LibiGel's prospects for the treatment of female sexual dysfunction.